Pub Date : 2025-08-29eCollection Date: 2025-07-01DOI: 10.1177/15593258251374411
Paul A Oakley, Jason W Haas, Deed E Harrison
Postural alignment is a critical determinant of health status. Its degradation is associated with deformity-caused and compensation-related back pain, neurologic involvement, osteoarthritic development, as well as disability and reduced quality of life. Radiography remains the most efficient method of evaluating standard sagittal and coronal spine and pelvic metrics that are used to plan surgical and nonsurgical treatment strategies. Many current spine guidelines dissuade the use of initial screening X-rays and some chiropractic guidelines condemn repeat imaging to assess progress from treatment regimens; these are anti-scientific viewpoints that ignore alternate viewpoints and evidence. Current understanding of the relationship between different spinopelvic parameters are essential to plan biomechanically appropriate interventions that are patient-specific. There are radiographically measured parameter thresholds critically related to several spinal disorders and positive patient outcomes. Current guidelines must include a caveat for contemporary biomechanical evaluation and its consequent specific treatments and should recommend routine radiographic imaging for spine patients undergoing corrective rehabilitative interventions. The failure to radiographically diagnose spinal deformity is argued to be negligence in many cases. The prime obstacle to routine X-ray imaging lies with the presumed threat of cancer, however, this is dogma; we summarize the main evidence from recent publications why this is so.
{"title":"The Rationale and Safety of Routine Imaging in Rehabilitative Spine Care: Delayed Radiographs for Patients Presenting With Spine Disorders is Debatable.","authors":"Paul A Oakley, Jason W Haas, Deed E Harrison","doi":"10.1177/15593258251374411","DOIUrl":"10.1177/15593258251374411","url":null,"abstract":"<p><p>Postural alignment is a critical determinant of health status. Its degradation is associated with deformity-caused and compensation-related back pain, neurologic involvement, osteoarthritic development, as well as disability and reduced quality of life. Radiography remains the most efficient method of evaluating standard sagittal and coronal spine and pelvic metrics that are used to plan surgical and nonsurgical treatment strategies. Many current spine guidelines dissuade the use of initial screening X-rays and some chiropractic guidelines condemn repeat imaging to assess progress from treatment regimens; these are anti-scientific viewpoints that ignore alternate viewpoints and evidence. Current understanding of the relationship between different spinopelvic parameters are essential to plan biomechanically appropriate interventions that are patient-specific. There are radiographically measured parameter thresholds critically related to several spinal disorders and positive patient outcomes. Current guidelines must include a caveat for contemporary biomechanical evaluation and its consequent specific treatments and should recommend routine radiographic imaging for spine patients undergoing corrective rehabilitative interventions. The failure to radiographically diagnose spinal deformity is argued to be negligence in many cases. The prime obstacle to routine X-ray imaging lies with the presumed threat of cancer, however, this is dogma; we summarize the main evidence from recent publications why this is so.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251374411"},"PeriodicalIF":2.4,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12397594/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The elevated mortality rate associated with sepsis is a primary global health concern. The correlation between bicarbonate levels and mortality risk in sepsis remains unclear.
Method: A retrospective cohort study was conducted using data from the MIMIC-IV database, including 12 744 adult sepsis patients. The primary exposure was serum bicarbonate levels, categorized into quintiles. The primary outcome was 28-day mortality, and secondary outcomes included 90-day mortality. Multivariable Cox regression models adjusted for demographic, clinical, and laboratory variables were used to examine the relationship between bicarbonate levels and mortality. Curve fitting and sensitivity analyses were performed to validate the findings.
Results: A U-shaped relationship between serum bicarbonate levels and 28-day mortality was identified. Both low (≤19.0 mEq/L) and high (>26.0 mEq/L) bicarbonate levels were associated with increased mortality risk. Patients with bicarbonate levels between 24.0-26.0 mEq/L had the lowest 28-day mortality. The relationship remained consistent across subgroups, and an inflection point was observed at 25.0 mEq/L. Sensitivity analyses confirmed the robustness of the findings across different data imputations.
Conclusion: This study demonstrates that both low and high serum bicarbonate levels are associated with increased mortality in sepsis patients. The optimal bicarbonate range for minimizing mortality risk appears to be between 24.0-26.0 mEq/L. These findings highlight the importance of monitoring bicarbonate levels in clinical practice, suggesting that maintaining bicarbonate within this range may improve patient outcomes. Further prospective studies are needed to confirm these findings and explore potential therapeutic strategies.
{"title":"The U-Shaped Relationship Between Serum Bicarbonate Levels and 28-Day Mortality in Patients With Sepsis: A Retrospective Cohort Study of MIMIC-IV Database.","authors":"Minghao Liang, Feilong Guan, Lili Sun, Wenjing Xi, Hongling Jia, Yifei Xu, Minyan Jin, Xianhai Chen, Di Huang, Zhanjun Qiu","doi":"10.1177/15593258251374417","DOIUrl":"10.1177/15593258251374417","url":null,"abstract":"<p><strong>Background: </strong>The elevated mortality rate associated with sepsis is a primary global health concern. The correlation between bicarbonate levels and mortality risk in sepsis remains unclear.</p><p><strong>Method: </strong>A retrospective cohort study was conducted using data from the MIMIC-IV database, including 12 744 adult sepsis patients. The primary exposure was serum bicarbonate levels, categorized into quintiles. The primary outcome was 28-day mortality, and secondary outcomes included 90-day mortality. Multivariable Cox regression models adjusted for demographic, clinical, and laboratory variables were used to examine the relationship between bicarbonate levels and mortality. Curve fitting and sensitivity analyses were performed to validate the findings.</p><p><strong>Results: </strong>A U-shaped relationship between serum bicarbonate levels and 28-day mortality was identified. Both low (≤19.0 mEq/L) and high (>26.0 mEq/L) bicarbonate levels were associated with increased mortality risk. Patients with bicarbonate levels between 24.0-26.0 mEq/L had the lowest 28-day mortality. The relationship remained consistent across subgroups, and an inflection point was observed at 25.0 mEq/L. Sensitivity analyses confirmed the robustness of the findings across different data imputations.</p><p><strong>Conclusion: </strong>This study demonstrates that both low and high serum bicarbonate levels are associated with increased mortality in sepsis patients. The optimal bicarbonate range for minimizing mortality risk appears to be between 24.0-26.0 mEq/L. These findings highlight the importance of monitoring bicarbonate levels in clinical practice, suggesting that maintaining bicarbonate within this range may improve patient outcomes. Further prospective studies are needed to confirm these findings and explore potential therapeutic strategies.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251374417"},"PeriodicalIF":2.4,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-25eCollection Date: 2025-07-01DOI: 10.1177/15593258251371484
Chun Chen, Chuanpeng Yang, Shuning Hu, Wenjie Nie, Sudan Ye, Minghao Lu, Xingjie Xu, Huajun Hu
Objectives: We aimed to investigate the concentration of adenosine (ADO) in the tumor microenvironment (TME), focusing on its potential to modulate tumor cells and natural killer (NK) cells, thereby facilitating tumor immune escape.
Methods: In this study, an in vitro simulation system was developed to systematically evaluate the effects of ADO (0-500 μM) on the colony formation and migration capability of A549 (lung carcinoma) and A375 (melanoma) cell lines, as well as its action on NK92 cell activity, cytokine secretion, and cytotoxicity against tumor cells.
Results: The results showed that 50 μM ADO significantly promoted tumor cell proliferation (increasing the colony formation rate by 60%-80%) and migration (increasing the migration rate by 30%-40%), whereas high concentrations (>200 μM) exhibited an inhibitory effect. ADO suppressed NK92 cell activity in a dose-dependent manner, reducing the relative proliferation rate by 14.5% at 50 μM, significantly decreasing IFN-γ secretion (by 24% at 50 μM), and impairing the killing efficiency of A549, A375, and HepG2 cells (reducing their respective cytotoxicity by 20.3%, 22.4%, and 31.5%).
Conclusion: This study provides biological evidence that 50 μM represents a critical threshold concentration for TME simulation, elucidates the concentration-dependent bidirectional regulation of ADO.
{"title":"Adenosine Concentration Determination for <i>in Vitro</i> Tumor Microenvironment Simulation.","authors":"Chun Chen, Chuanpeng Yang, Shuning Hu, Wenjie Nie, Sudan Ye, Minghao Lu, Xingjie Xu, Huajun Hu","doi":"10.1177/15593258251371484","DOIUrl":"10.1177/15593258251371484","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to investigate the concentration of adenosine (ADO) in the tumor microenvironment (TME), focusing on its potential to modulate tumor cells and natural killer (NK) cells, thereby facilitating tumor immune escape.</p><p><strong>Methods: </strong>In this study, an in vitro simulation system was developed to systematically evaluate the effects of ADO (0-500 μM) on the colony formation and migration capability of A549 (lung carcinoma) and A375 (melanoma) cell lines, as well as its action on NK92 cell activity, cytokine secretion, and cytotoxicity against tumor cells.</p><p><strong>Results: </strong>The results showed that 50 μM ADO significantly promoted tumor cell proliferation (increasing the colony formation rate by 60%-80%) and migration (increasing the migration rate by 30%-40%), whereas high concentrations (>200 μM) exhibited an inhibitory effect. ADO suppressed NK92 cell activity in a dose-dependent manner, reducing the relative proliferation rate by 14.5% at 50 μM, significantly decreasing IFN-γ secretion (by 24% at 50 μM), and impairing the killing efficiency of A549, A375, and HepG2 cells (reducing their respective cytotoxicity by 20.3%, 22.4%, and 31.5%).</p><p><strong>Conclusion: </strong>This study provides biological evidence that 50 μM represents a critical threshold concentration for TME simulation, elucidates the concentration-dependent bidirectional regulation of ADO.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251371484"},"PeriodicalIF":2.4,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-19eCollection Date: 2025-07-01DOI: 10.1177/15593258251367613
Fengwei Zhang, Mohamed Farouk Elsadek, Shafqat Rasul Chaudhry, Nojood Altwaijry, Shamsuddin Sultan Khan, Seyedeh Fatemeh Jafari, Aman Shah Abdul Majid, Chern Ein Oon, Amin Malik Shah Abdul Majid, Thomas Efferth, Muhammad Asif
Objectives: The current study investigated angiogenesis-arresting attributes of Mesua ferrea oleo-gum resin extract and its underlying molecular mechanisms.
Methods: Series of invitro, exvivo and invivo models were used to assess anti-angiogenic properties.
Results: MTT cell viability experiments showed that oleo-gum resin extract induced moderate cytotoxicity towards EA.hy926 cells (IC50 = 42 µg/mL). Extract-treated cells showed significant reduction in invasion, migration, and tube formation potential. At the protein level, down-regulation in expression of angiopoietin-1 and -2, Tie-2, MMP-1 and -9, VEGF-A, and VEGFR2 pro-angiogenic proteins was observed in extract-treated EA.hy926 cells. Signalling array data indicated a marked down-regulation of transcription factors, i.e., HIF-1α and WNT (-3.68 ± 5.74 and -6.24 ± 6.50 fold-change). Furthermore, extract treatment diminished vessel-sprouting in in vitro 3D spheroids, exvivo rat aorta ring, and invivo chick embryo chorioallantoic membrane models. Treatment with extract significantly reduced intracellular ROS and caspases-8 and -9 levels. GC-MS and HPLC analyses of extract indicated the presence of (+)-α-longipinene, isoledene, cedrene and α-elemene. ADMET prediction of detected compounds revealed good intestinal absorption (> 90%) and skin permeability (log Kp < -2.5), making the extract a suitable candidate for the treatment of angiogenesis-associated intestinal and skin disorders.
Conclusion: Overall, these findings suggest that Mesua ferrea extract exhibits anti-angiogenic properties by down-regulating the VEGF/angiopoietin axis, warranting further investigations in treating angiogenesis-associated diseases.
{"title":"<i>Mesua ferrea</i> L. extract Attenuates Angiogenesis Through HIF-1α and WNT Mediated Blockage of VEGF/Angiopoietin Axis.","authors":"Fengwei Zhang, Mohamed Farouk Elsadek, Shafqat Rasul Chaudhry, Nojood Altwaijry, Shamsuddin Sultan Khan, Seyedeh Fatemeh Jafari, Aman Shah Abdul Majid, Chern Ein Oon, Amin Malik Shah Abdul Majid, Thomas Efferth, Muhammad Asif","doi":"10.1177/15593258251367613","DOIUrl":"10.1177/15593258251367613","url":null,"abstract":"<p><strong>Objectives: </strong>The current study investigated angiogenesis-arresting attributes of <i>Mesua ferrea</i> oleo-gum resin extract and its underlying molecular mechanisms.</p><p><strong>Methods: </strong>Series of <i>in</i> <i>vitro</i>, <i>ex</i> <i>vivo</i> and <i>in</i> <i>vivo</i> models were used to assess anti-angiogenic properties.</p><p><strong>Results: </strong>MTT cell viability experiments showed that oleo-gum resin extract induced moderate cytotoxicity towards EA.hy926 cells (IC<sub>50</sub> = 42 µg/mL). Extract-treated cells showed significant reduction in invasion, migration, and tube formation potential. At the protein level, down-regulation in expression of angiopoietin-1 and -2, Tie-2, MMP-1 and -9, VEGF-A, and VEGFR2 pro-angiogenic proteins was observed in extract-treated EA.hy926 cells. Signalling array data indicated a marked down-regulation of transcription factors, i.e., HIF-1α and WNT (-3.68 ± 5.74 and -6.24 ± 6.50 fold-change). Furthermore, extract treatment diminished vessel-sprouting in <i>in vitro</i> 3D spheroids, <i>ex</i> <i>vivo</i> rat aorta ring, and <i>in</i> <i>vivo</i> chick embryo chorioallantoic membrane models. Treatment with extract significantly reduced intracellular ROS and caspases-8 and -9 levels. GC-MS and HPLC analyses of extract indicated the presence of (+)-α-longipinene, isoledene, cedrene and α-elemene. ADMET prediction of detected compounds revealed good intestinal absorption (> 90%) and skin permeability (log Kp < -2.5), making the extract a suitable candidate for the treatment of angiogenesis-associated intestinal and skin disorders.</p><p><strong>Conclusion: </strong>Overall, these findings suggest that <i>Mesua ferrea</i> extract exhibits anti-angiogenic properties by down-regulating the VEGF/angiopoietin axis, warranting further investigations in treating angiogenesis-associated diseases.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251367613"},"PeriodicalIF":2.4,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144946583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-11eCollection Date: 2025-07-01DOI: 10.1177/15593258251367627
Omayma A R Abozaid, Fatma S M Moawed, Hanaa F B Gabr, Marwa A Esmat
Objectives: MiR-107 upregulation represents a key target among the multiple pathways associated with T2DM. Given that drug combinations offer significant therapeutic potential, this study investigated the antidiabetic, antioxidant, and anti-inflammatory effects of γ-irradiation, the quercetin (common flavonol), and the metformin (biguanide) on HFD/STZ-induced diabetic rats' brains. Methods: Diabetic rats were treated with metformin (200 mg/kg b.w./day) alone or in combination with quercetin (30 mg/kg b.w./day) and/or γ-radiation (fractionated 4 Gy) for 4 weeks. Results: The diabetic group exhibited increased body weight, blood glucose, HOMA-IR, AChE, MMP-2, and lipid peroxidation, while serum insulin and brain GPx antioxidant enzyme activity were significantly decreased. Similarly, BDNF and SIRTI transcript levels and IRS1 protein expression were reduced, whereas NF-κB and MiR-107 transcript levels were elevated in diabetic rats compared to controls. Histopathological examination of diabetic brain tissue corroborated the biochemical findings. Treatment with metformin alone or in combination with γ-irradiation and/or quercetin effectively mitigated these effects by downregulating miR-107 and improving brain function, with optimal results achieved through combined therapy. Conclusion: The synergistic combination of Metformin, fractionated gamma-irradiation, and quercetin effectively attenuates brain injury in diabetic rats by enhancing IRS1/SIRT1/BDNF signaling while suppressing MiR-107/NF-κB pathways.
{"title":"Combined Effects of Metformin, Quercetin, and Fractionated Gamma Irradiation on MiR-107-Mediated Brain Injury in HFD/STZ-Induced Diabetic Rats.","authors":"Omayma A R Abozaid, Fatma S M Moawed, Hanaa F B Gabr, Marwa A Esmat","doi":"10.1177/15593258251367627","DOIUrl":"10.1177/15593258251367627","url":null,"abstract":"<p><p><b>Objectives:</b> MiR-107 upregulation represents a key target among the multiple pathways associated with T2DM. Given that drug combinations offer significant therapeutic potential, this study investigated the antidiabetic, antioxidant, and anti-inflammatory effects of γ-irradiation, the quercetin (common flavonol), and the metformin (biguanide) on HFD/STZ-induced diabetic rats' brains. <b>Methods:</b> Diabetic rats were treated with metformin (200 mg/kg b.w./day) alone or in combination with quercetin (30 mg/kg b.w./day) and/or γ-radiation (fractionated 4 Gy) for 4 weeks. <b>Results:</b> The diabetic group exhibited increased body weight, blood glucose, HOMA-IR, AChE, MMP-2, and lipid peroxidation, while serum insulin and brain GPx antioxidant enzyme activity were significantly decreased. Similarly, BDNF and SIRTI transcript levels and IRS1 protein expression were reduced, whereas NF-κB and MiR-107 transcript levels were elevated in diabetic rats compared to controls. Histopathological examination of diabetic brain tissue corroborated the biochemical findings. Treatment with metformin alone or in combination with γ-irradiation and/or quercetin effectively mitigated these effects by downregulating miR-107 and improving brain function, with optimal results achieved through combined therapy. <b>Conclusion:</b> The synergistic combination of Metformin, fractionated gamma-irradiation, and quercetin effectively attenuates brain injury in diabetic rats by enhancing IRS1/SIRT1/BDNF signaling while suppressing MiR-107/NF-κB pathways.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251367627"},"PeriodicalIF":2.4,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12340211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144834416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-05eCollection Date: 2025-07-01DOI: 10.1177/15593258251349653
Yaqin Huang, Jian Wu, Li Zheng, Gen Huang, Bin Li, Lihong Gan, Ling Yao
Objectives: Ginseng and its extracts have shown promising therapeutic effects on gastric cancer (GC). We aimed to investigate the functions and potential mechanisms of Ginsenoside Rk1 (Rk1) on GC.
Methods: GC cell lines were treated with different doses of Rk1. The CCK-8 assay and BrdU assay were used to measure cell viability and proliferation. A Transwell assay was used to evaluate cell invasion and migration. A TUNEL assay was used to assess cell apoptosis. RT-PCR was conducted to detect apoptosis-associated genes. Western blotting was used to determine the activation of the AMPK/mTOR pathway. An in vivo tumor-bearing nude mouse model was generated to investigate the impact of Rk1 on tumor growth.
Results: Rk1 inhibited the proliferation, migration, invasion, and EMT of GC cells and promoted cell apoptosis. It also enhances the sensitivity of GC cells to chemotherapy drugs (including 5-fluorouracil, vincristine, cisplatin, and oxaliplatin). Mechanistically, Rk1 increased AMPK phosphorylation and repressed mTOR phosphorylation. AMPK inhibition strongly decreased the inhibitory effect of Rk1 on GC cells. In-vivo assays suggested that Rk1 considerably hindered GC growth and had synergistic effects when combined with cisplatin or oxaliplatin.
Conclusion: Ginsenoside Rk1 exerts an antitumor effect on GC by activating the AMPK/mTOR pathway.
{"title":"Ginsenoside Rk1 Enhances Chemosensitivity of Gastric Cancer Through Activating the AMPK/mTOR Pathway.","authors":"Yaqin Huang, Jian Wu, Li Zheng, Gen Huang, Bin Li, Lihong Gan, Ling Yao","doi":"10.1177/15593258251349653","DOIUrl":"10.1177/15593258251349653","url":null,"abstract":"<p><strong>Objectives: </strong>Ginseng and its extracts have shown promising therapeutic effects on gastric cancer (GC). We aimed to investigate the functions and potential mechanisms of Ginsenoside Rk1 (Rk1) on GC.</p><p><strong>Methods: </strong>GC cell lines were treated with different doses of Rk1. The CCK-8 assay and BrdU assay were used to measure cell viability and proliferation. A Transwell assay was used to evaluate cell invasion and migration. A TUNEL assay was used to assess cell apoptosis. RT-PCR was conducted to detect apoptosis-associated genes. Western blotting was used to determine the activation of the AMPK/mTOR pathway. An in vivo tumor-bearing nude mouse model was <i>generated</i> to investigate the impact of Rk1 on tumor growth.</p><p><strong>Results: </strong>Rk1 inhibited the proliferation, migration, invasion, and EMT of GC cells and promoted cell apoptosis. It also enhances the sensitivity of GC cells to chemotherapy drugs (including 5-fluorouracil, vincristine, cisplatin, and oxaliplatin). Mechanistically, Rk1 increased AMPK phosphorylation and repressed mTOR phosphorylation. AMPK inhibition strongly decreased the inhibitory effect of Rk1 on GC cells. <i>In-vivo</i> assays suggested that Rk1 considerably hindered GC growth and had synergistic effects when combined with cisplatin or oxaliplatin.</p><p><strong>Conclusion: </strong>Ginsenoside Rk1 exerts an antitumor effect on GC by activating the AMPK/mTOR pathway.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251349653"},"PeriodicalIF":2.4,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12326108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144793770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-19eCollection Date: 2025-07-01DOI: 10.1177/15593258251360051
Abolfazl Kanani, Julianna Krasowska, Krzysztof W Fornalski, Joseph John Bevelacqua, James Welsh, Smj Mortazavi
Objectives: Radiation Adaptive Response (AR) is a biological phenomenon in which exposure to low-dose radiation (LDR) enhances an organism's ability to withstand subsequent higher doses. This scoping review explores AR across multiple disciplines, summarizing evidence, identifying research gaps, and evaluating potential applications in cancer therapy, neurodegenerative disease management, space medicine, and pandemic response.
Methods: A comprehensive review of experimental/clinical studies on AR was conducted, focusing on molecular mechanisms, biological implications, biophysical modeling, and translational applications.
Results: In oncology, AR has shown promise in selectively protecting normal tissues during radiotherapy while sensitizing tumor cells, yet its effects remain cell-type dependent. LDR may manage neurodegenerative diseases by modulating oxidative stress and inflammation. In space medicine, AR-based astronaut selection has been proposed as a novel strategy to mitigate radiation risks during long-term space missions, although empirical validation is lacking. LDR therapy for managing COVID-19 pneumonia has been explored, but ethical concerns and long-term safety risks require further investigation.
Conclusion: Despite AR's potential, its clinical and spaceflight implementation requires mechanistic elucidation, standardized protocols, and rigorous studies. The risks of tumorigenesis, individual variability in AR, and potential immunomodulatory effects must be evaluated before widespread application. Moreover, inconsistent AR appearance complicates its study and clinical use.
{"title":"Adaptive Response: A Scoping Review of Its Implications in Medicine, Space Exploration, and Beyond.","authors":"Abolfazl Kanani, Julianna Krasowska, Krzysztof W Fornalski, Joseph John Bevelacqua, James Welsh, Smj Mortazavi","doi":"10.1177/15593258251360051","DOIUrl":"10.1177/15593258251360051","url":null,"abstract":"<p><strong>Objectives: </strong>Radiation Adaptive Response (AR) is a biological phenomenon in which exposure to low-dose radiation (LDR) enhances an organism's ability to withstand subsequent higher doses. This scoping review explores AR across multiple disciplines, summarizing evidence, identifying research gaps, and evaluating potential applications in cancer therapy, neurodegenerative disease management, space medicine, and pandemic response.</p><p><strong>Methods: </strong>A comprehensive review of experimental/clinical studies on AR was conducted, focusing on molecular mechanisms, biological implications, biophysical modeling, and translational applications.</p><p><strong>Results: </strong>In oncology, AR has shown promise in selectively protecting normal tissues during radiotherapy while sensitizing tumor cells, yet its effects remain cell-type dependent. LDR may manage neurodegenerative diseases by modulating oxidative stress and inflammation. In space medicine, AR-based astronaut selection has been proposed as a novel strategy to mitigate radiation risks during long-term space missions, although empirical validation is lacking. LDR therapy for managing COVID-19 pneumonia has been explored, but ethical concerns and long-term safety risks require further investigation.</p><p><strong>Conclusion: </strong>Despite AR's potential, its clinical and spaceflight implementation requires mechanistic elucidation, standardized protocols, and rigorous studies. The risks of tumorigenesis, individual variability in AR, and potential immunomodulatory effects must be evaluated before widespread application. Moreover, inconsistent AR appearance complicates its study and clinical use.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251360051"},"PeriodicalIF":2.3,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12276503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144674131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-11eCollection Date: 2025-07-01DOI: 10.1177/15593258251360056
Eman A Alanazy, Daoud Ali, Mohammed H A Almarzoug, Khadijah N Yaseen, Bader O Almutairi, Saad Alkahtani, Badr A Aldahmash, Saud Alarifi
In this study we used biosynthesis methods to create bimetallic nickel cobalt nanoparticles (Ni-Co NPs) utilizing seaweed. Before exposure to target cells, the characterization of Ni-Co NPs is done by UV-Vis spectrophotometry, EDX, SEM, TEM, the shape of g Ni-Co NPs are polygonal form and its size is measured 38.27 ± 3 nm. The cytotoxic effect of g Ni-Co NPs on HuH7 and HCT cells were determined by MTT and NRU assays. The cytotoxicity of NPs increased in a concentration dependent manner and it showed high cytotoxic effect on HCT-116 cells than HuH-7 cells. We determined IC50 24 h for HuH-7 and HCT -116 cells at 24 h, it was 65.84 and 24.73 μg/mL, respectively. ROS was elevated at higher concentration of Ni-Co NPs. LPO was increased at 16 μg/mL in HuH-7 cells and 19 μg/mL in HCT-116 cells. CAT was reduced in HCT-116 cells than HuH-7 cells high concentration of NPs. JC-1 staining, the loss of MMP in control, Ni-Co NPs exposed cell were evaluated. In HuH-7 and HCT-116 cells, maximum apoptotic cells were observed at high concentration. Apoptotic genes were expressed in both type cells. The above findings highlight the significance of Ni-Co NPs and useful in a number of cancer treatments.
{"title":"Utilizing of Seaweed for Eco-friendly Synthesis of Nickel Cobalt Nanoparticles and Assessment of its Cytotoxic Effects on Human Liver and Colon Cancer Cells.","authors":"Eman A Alanazy, Daoud Ali, Mohammed H A Almarzoug, Khadijah N Yaseen, Bader O Almutairi, Saad Alkahtani, Badr A Aldahmash, Saud Alarifi","doi":"10.1177/15593258251360056","DOIUrl":"10.1177/15593258251360056","url":null,"abstract":"<p><p>In this study we used biosynthesis methods to create bimetallic nickel cobalt nanoparticles (Ni-Co NPs) utilizing seaweed. Before exposure to target cells, the characterization of Ni-Co NPs is done by UV-Vis spectrophotometry, EDX, SEM, TEM, the shape of g Ni-Co NPs are polygonal form and its size is measured 38.27 ± 3 nm. The cytotoxic effect of g Ni-Co NPs on HuH7 and HCT cells were determined by MTT and NRU assays. The cytotoxicity of NPs increased in a concentration dependent manner and it showed high cytotoxic effect on HCT-116 cells than HuH-7 cells. We determined IC<sub>50</sub> 24 h for HuH-7 and HCT -116 cells at 24 h, it was 65.84 and 24.73 μg/mL, respectively. ROS was elevated at higher concentration of Ni-Co NPs. LPO was increased at 16 μg/mL in HuH-7 cells and 19 μg/mL in HCT-116 cells. CAT was reduced in HCT-116 cells than HuH-7 cells high concentration of NPs. JC-1 staining, the loss of MMP in control, Ni-Co NPs exposed cell were evaluated. In HuH-7 and HCT-116 cells, maximum apoptotic cells were observed at high concentration. Apoptotic genes were expressed in both type cells. The above findings highlight the significance of Ni-Co NPs and useful in a number of cancer treatments.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251360056"},"PeriodicalIF":2.3,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12254618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144625597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-07eCollection Date: 2025-07-01DOI: 10.1177/15593258251359335
Bobby R Scott
Background: Previously the author was unable to develop a formal mathematical characterization of his probability-based hormetic relative risk (HRR) model for cancer prevention/elimination by absorbed doses (D) of ionizing radiation in the hormetic zone where D < Dt (population absorbed dose threshold for cancer induction).
Objective: To develop a formal mathematical characterization of the HRR model's disease prevention function DPF(D), which is the cancer prevention/elimination probability.
Approach: Use distributed (over a population) individual-specific, natural-defenses-enhancing (E) and suppressing (S) dose thresholds.
Results: DPF(D) is now mathematically characterized based on Weibull-type E and S thresholds distributions. The E thresholds predominate at very low radiation doses and the S thresholds predominate at higher doses just below Dt. This leads to a hormetic dose-response relationship for cancer relative risk RR(D) (= 1 - DPF(D)) for doses from zero (representing natural background radiation exposure) to dose Dt. The greatly improved HRR model is quite flexible and was applied to lung cancer and reticulum cell sarcoma prevention/elimination data from a study involving more than 15 000 gamma-ray exposed mice.
Conclusion: The System of Radiological Protection needs to be updated to account for health benefits rather than invalid LNT-hypothesis-based phantom radiation-caused cancers from radiation doses < Dt.
背景:在此之前,作者无法对其基于概率的辐照相对危险度(HRR)模型进行正式的数学表征,该模型用于在D < D t(诱导癌症的人群吸收剂量阈值)的辐照区通过电离辐射的吸收剂量(D)预防/消除癌症。目的:建立HRR模型疾病预防函数DPF(D)的形式化数学表征,即癌症预防/消除概率。方法:使用分布的(在人群中)个体特异性的、增强自然防御(E)和抑制(S)剂量阈值。结果:DPF(D)现在基于weibull型E和S阈值分布进行数学表征。E阈值占主导地位在非常低的辐射剂量和高剂量的年代阈值占主导地位略低于D t。这导致癌症激效剂量反应关系的相对风险RR (D) (= 1 - DPF (D))的剂量从0(代表自然背景辐射)剂量D t。大大提高了嗯模型非常灵活,并且应用于肺癌和网状细胞肉瘤预防/消除数据从000年一项研究涉及超过15伽马射线暴露出来老鼠。结论:放射防护系统需要更新,以考虑健康效益,而不是无效的基于llt假设的辐射剂量< D t的幻像辐射引起的癌症。
{"title":"A Breakthrough on Modeling Cancer Prevention and Elimination by Low Radiation Doses.","authors":"Bobby R Scott","doi":"10.1177/15593258251359335","DOIUrl":"10.1177/15593258251359335","url":null,"abstract":"<p><strong>Background: </strong>Previously the author was unable to develop a formal mathematical characterization of his probability-based hormetic relative risk (HRR) model for cancer prevention/elimination by absorbed doses (<i>D</i>) of ionizing radiation in the hormetic zone where <i>D</i> < <i>D</i> <sub>t</sub> (population absorbed dose threshold for cancer induction).</p><p><strong>Objective: </strong>To develop a formal mathematical characterization of the HRR model's disease prevention function <i>DPF</i>(<i>D</i>), which is the cancer prevention/elimination probability.</p><p><strong>Approach: </strong>Use distributed (over a population) individual-specific, natural-defenses-enhancing (E) and suppressing (S) dose thresholds.</p><p><strong>Results: </strong><i>DPF</i>(<i>D</i>) is now mathematically characterized based on Weibull-type E and S thresholds distributions. The E thresholds predominate at very low radiation doses and the S thresholds predominate at higher doses just below <i>D</i> <sub>t</sub>. This leads to a hormetic dose-response relationship for cancer relative risk <i>RR</i>(<i>D</i>) (= 1 - <i>DPF</i>(<i>D</i>)) for doses from zero (representing natural background radiation exposure) to dose <i>D</i> <sub>t</sub>. The greatly improved HRR model is quite flexible and was applied to lung cancer and reticulum cell sarcoma prevention/elimination data from a study involving more than 15 000 gamma-ray exposed mice.</p><p><strong>Conclusion: </strong>The System of Radiological Protection needs to be updated to account for health benefits rather than invalid LNT-hypothesis-based phantom radiation-caused cancers from radiation doses < <i>D</i> <sub>t</sub>.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 3","pages":"15593258251359335"},"PeriodicalIF":2.3,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12235108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-29eCollection Date: 2025-04-01DOI: 10.1177/15593258251356102
Yuta Shibamoto
In comparing magnetic resonance imaging (MRI) and computed tomography (CT), it is often stated thata significant advantage of MRI is its lack of ionizing radiation, which may contribute to carcinogenesis. This article questions whether this concern is justified. First, the basis for the linear no-threshold (LNT) hypothesis, which suggests a carcinogenic potential of CT, is now considered weak. Historically, the foundation of the LNT model was not grounded in robust scientific data, and the epidemiological evidence indicating an increased cancer incidence in children undergoing CTscans is not scientifically reliable. Both MRI and CT examinations elevate reactive oxygen species, leading to DNA damage, chromosomal aberrations, and micronucleus formation. Following a single scan with either MRI or CT, the γH2AX index in human lymphocytes increased to a similar degree; however, the small amounts of DNA damage produced are efficiently repaired, thus not resulting in carcinogenesis. While it may be argued that ionizing radiation induces more complex DNA damage than electromagnetic fields, no studies have compared the quality of DNA damage between MRI and CT at clinically relevant exposure levels. Considering the effective defense mechanisms of living organisms, infrequent MRI and CT examinations do not appear to pose an increased risk of carcinogenesis.
{"title":"Magnetic Resonance Imaging and Computed Tomography May Carry Similar (but Very Low) Risks of Carcinogenesis.","authors":"Yuta Shibamoto","doi":"10.1177/15593258251356102","DOIUrl":"10.1177/15593258251356102","url":null,"abstract":"<p><p>In comparing magnetic resonance imaging (MRI) and computed tomography (CT), it is often stated thata significant advantage of MRI is its lack of ionizing radiation, which may contribute to carcinogenesis. This article questions whether this concern is justified. First, the basis for the linear no-threshold (LNT) hypothesis, which suggests a carcinogenic potential of CT, is now considered weak. Historically, the foundation of the LNT model was not grounded in robust scientific data, and the epidemiological evidence indicating an increased cancer incidence in children undergoing CTscans is not scientifically reliable. Both MRI and CT examinations elevate reactive oxygen species, leading to DNA damage, chromosomal aberrations, and micronucleus formation. Following a single scan with either MRI or CT, the γH2AX index in human lymphocytes increased to a similar degree; however, the small amounts of DNA damage produced are efficiently repaired, thus not resulting in carcinogenesis. While it may be argued that ionizing radiation induces more complex DNA damage than electromagnetic fields, no studies have compared the quality of DNA damage between MRI and CT at clinically relevant exposure levels. Considering the effective defense mechanisms of living organisms, infrequent MRI and CT examinations do not appear to pose an increased risk of carcinogenesis.</p>","PeriodicalId":11285,"journal":{"name":"Dose-Response","volume":"23 2","pages":"15593258251356102"},"PeriodicalIF":2.3,"publicationDate":"2025-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12206961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}